Effects of Pre-dialysis Resistance Training on Sarcopenia, Inflammatory Profile, and Anemia Biomarkers in Older Community-dwelling Patients with Chronic Kidney Disease: a Randomized Controlled Trial
Overview
Authors
Affiliations
Background: Sarcopenia and chronic kidney disease (CKD) have been associated with negative outcomes in older people, including inflammatory profile and anemia biomarkers.
Aims: To investigate the effects of pre-dialysis resistance training (RT) on sarcopenia, inflammatory profile, and anemia biomarkers in older patients with CKD.
Methods: A total of 107 patients with CKD (65.4 ± 3.7 years) were randomly allocated into four groups: sarcopenic RT (n = 37), non-sarcopenic RT (n = 20), sarcopenic control (n = 28), and non-sarcopenic control (n = 22). DXA and handgrip strength were used to classify sarcopenia according to EWGSOP-2. Treatment groups underwent a 24-week intervention with RT before each dialysis session, three times per week. Blood sample analysis for ferritin, hepcidin, iron availability, and inflammatory profile (TNFα, IL-6, and IL-10) was conducted. All-cause mortality was recorded over 5 years.
Results: Sarcopenic RT group increased iron availability after the intervention, while their counterparts decreased. Ferritin and hepcidin significantly decreased in sarcopenic RT group. RT elicited a reduction in both TNFα and IL-6, while increasing IL-10 in both intervention groups. The rate of sarcopenic subjects substantially decreased after the intervention period (from 37 to 17 in the RT group; p = 0.01). The proportion of deaths was higher (P = 0.033) for sarcopenic subjects (Controls 35.7% vs RT 29.7%) when compared to non-sarcopenic subjects (Controls 18% vs RT 10%). The proportion of deaths decreased according to the randomization group (X2 = 8.704; P < 0.1).
Conclusions: The 24-week RT intervention elicited a better sarcopenia status, better inflammatory profile, and improved anemia biomarkers. Sarcopenia was associated with higher mortality rate in older patients with CKD.
Aging and chronic kidney disease: epidemiology, therapy, management and the role of immunity.
Tang Y, Jiang J, Zhao Y, Du D Clin Kidney J. 2025; 17(9):sfae235.
PMID: 40034487 PMC: 11873799. DOI: 10.1093/ckj/sfae235.
Ru Q, Li Y, Zhang X, Chen L, Wu Y, Min J Bone Res. 2025; 13(1):27.
PMID: 40000618 PMC: 11861620. DOI: 10.1038/s41413-024-00398-6.
Correa H, Rosa T, Santos R, Mestrinho V, Aquino T, Santos W Front Physiol. 2025; 15():1444976.
PMID: 39835199 PMC: 11743718. DOI: 10.3389/fphys.2024.1444976.
Abrahim S, Steele A, Voth J, Krepinsky J, Lanktree M, Hawke T Physiol Rep. 2024; 12(15):e16151.
PMID: 39134506 PMC: 11319065. DOI: 10.14814/phy2.16151.
Heitman K, Alexander M, Faul C Int J Mol Sci. 2024; 25(10).
PMID: 38791164 PMC: 11121428. DOI: 10.3390/ijms25105117.